EL · Estee Lauder Companies Inc
$93.30
+0.00 (+0.00%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$33.76B
Shares
361.80M
Volume · Oct 5
2.79M
Avg daily vol (3M)
2.96M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$93.30
Open$94.00
Day$92.93–94.80
52W close$67.23–119.61
Avg vol 30d3.1M
Short int7.1M · 2.0% float · 2.5d
Short vol43%
Last earningsAug 4, 2027
DataJan 2020–Oct 2026
Filing10-K · Aug 19
Up next
Next earnings call
Nov 2, 2026
Scheduled
· in 4 wks
filed Aug 19, 2026
call held Aug 19, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$15.05B
Trailing 12 months
Net income (TTM)
$182.00M
Trailing 12 months
Revenue growth YoY
+6.3%
Year over year
Operating margin
5.2%
Trailing 12 months
P / E (TTM)
183.9
Trailing earnings · reciprocal yield 0.5%
FCF yield
3.9%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
1.5%
Trailing 12 months
Shares change YoY
+1.1%
Year over year · more shares
Price change (1Y)
+3.6%
Trailing year
Short interest
2.0%
Latest settlement · 2.5 days to cover
AI Brief
Q4 FY26 earnings call · Aug 19, 2026
Q4 FY26
TL;DR. Estée Lauder returned to organic sales growth in fiscal 2026 (+3% full year, +5% in Q4) with adjusted operating margin expanding 320 bps to 11.2% and adjusted diluted EPS up 66%, while raising its fiscal 2027 adjusted operating margin outlook to 12.7%–13.5% and affirming 3%–5% organic sales growth guidance; operating cash flow guidance, however, is being lowered to $1.3–1.4B for fiscal 2027.
Bullish
- + Raised fiscal 2027 adjusted operating margin outlook to 12.7%–13.5% from prior 12.5%–13.0%.
- + Jo Malone London and TOM FORD joined the billion-dollar brand club, bringing the portfolio to six.
- + Strong performance in China with 9% organic growth and share gains across categories.
Bearish
- − Hair Care organic net sales declined 1% in fiscal 2026.
- − Makeup adjusted operating results decreased to a loss position in fiscal 2026.
- − Fiscal 2027 net cash flows from operations guided to $1.3–$1.4B, down from $1.77B in fiscal 2026.
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+1%
above
Price vs 50-day avg
−1%
below
RSI (14)
46
neutral
MACD trend
Negative
52-week position
50%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−10%
trailing
6-month return
+22%
trailing
YTD return
−11%
this year
Relative strength
+11%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $94 › 200d $92 — 50d above 200d
Institutional flow
Accumulating
8 of 837 funds reported for Sep 30 · net +101.7K sh shares · +1 new
Insider flow
Distributing
Net -$11.8M over 90 days · 100% sells
Short interest
Rising
1.96% of float · ▲ +2.1% MoM · 2.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
837 holders — mid 3-yr range
Squeeze score
55
elevated · 0–100
Fundamentals
Revenue growth
+5%
Y/Y
Gross margin
76%
expanding
EPS growth
+116%
Y/Y
Free cash flow
$1.3B
Valuation
P/E 186.6
rich
Balance sheet
$3.8B
net debt
Quant / Vol
risk profile
Volatility
49%
annualized · 1-yr
Max drawdown
−44%
past year
ATR
3.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 19, 2026
Effective tax rate
· fiscal 27
Initiated
33% – 34%
Operating margin
· fiscal 27
Non-GAAP
Initiated
12.7% – 13.5%
Net cash flows from operating activities
· fiscal 27
Initiated
$1.3B – $1.4B
Guided vs delivered
· last 3 settled
Reported diluted net earnings per common share
Full Year Fiscal 2025
guided $2.52 – $2.76
$-3.15
Miss −219.3%
Reported diluted net earnings per common share
Twelve Months Ending June 30, 2024
guided $1.96 – $2.09
$1.08
Miss −46.7%
Reported diluted net earnings per common share
Twelve Months Ending June 30, 2023
guided $2.62 – $2.76
$2.79
Beat +3.7%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+1%
Bullish
Price vs 50-day avg
−1%
Neutral
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
50%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $94 › 200d $92 — 50d above 200d
Institutional flow
Accumulating
8 of 837 funds reported for Sep 30 · net +101.7K sh shares · +1 new
Insider flow
Distributing
Net -$11.8M over 90 days · 100% sells
Short interest
Rising
1.96% of float · ▲ +2.1% MoM · 2.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
837 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $67
Now $93 · 50%
Range high $120
vs 200-day avg +1%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted Net Earnings Per Common Share, Non-GAAP non-GAAP | $2.51 | Twelve Months Ended June 30 | — |
| Adjusted Diluted Net Earnings Per Common Share, Non-GAAP constant currency non-GAAP | $2.47 | Twelve Months Ended June 30 | — |
| Adjusted ETR, Non-GAAP non-GAAP | 35.7% | Twelve Months Ended June 30 | — |
| Adjusted Gross Margin, Non-GAAP non-GAAP | 75.5% | Twelve Months Ended June 30 | — |
| Adjusted Gross Profit non-GAAP | $11.37B | Year Ended June 30, 2026 | — |
| Adjusted Operating Income non-GAAP | $1.69B | Year Ended June 30, 2026 | — |
| Adjusted Operating Income - Non-GAAP (fourth quarter) non-GAAP | $267M | fourth quarter fiscal 2026 | — |
| Adjusted Operating Income, Non-GAAP constant currency non-GAAP | $1.67B | Twelve Months Ended June 30 | — |
GAAP → non-GAAP reconciliationGAAP Adjusted Operating Income, Non-GAAP 1.69B
-20M Impact of foreign currency translation
= Adjusted Operating Income, Non-GAAP constant currency 1.67B
|
|||
| Adjusted Operating Margin, Non-GAAP non-GAAP | 11.2% | Twelve Months Ended June 30 | — |
| Final net reduction in positions under PRGP restructuring program | 10,000 | full-year | — |
| Free Cash Flow non-GAAP | $1.32B | Year Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net cash flows provided by operating activities 1.77B
-457M Less: capital expenditures
= Free cash flow 1.32B
|
|||
| Full-year adjusted operating margin expansion non-GAAP | 320 | full-year fiscal 2026 | — |
| Full-year gross margin expansion | 150 | full-year fiscal 2026 | — |
| Mainland China adjusted operating income growth (full year) non-GAAP | 92% | full-year fiscal 2026 | — |
| Mainland China organic net sales growth (full year) non-GAAP | 9% | full-year fiscal 2026 | — |
| Organic Net Sales non-GAAP | $14.81B | Year Ended June 30, 2026 | — |
| Restructuring charges recognized in fiscal 2026 fourth quarter | $0.3B | fourth quarter | — |
| Restructuring charges recognized in fiscal 2026 full year | $0.8B | full-year | — |
| Skin Care adjusted operating income (full year) non-GAAP | $1.42B | full-year fiscal 2026 | — |
| Skin Care adjusted operating income growth (full year) non-GAAP | 52% | full-year fiscal 2026 | — |
| Total cumulative charges under the restructuring component of the PRGP (through June 30, 2026) | $1.4B | cumulative through June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EL
this stock
Estee Lauder Companies Inc
|
$33.76B | -10.9% | +5.0% | 186.6 | 2.0% |
|
PG
PROCTER & GAMBLE Co
|
$339.90B | +1.8% | +3.3% | 22.1 | 1.0% |
|
UL
Unilever PLC
|
$134.67B | -8.3% | — | — | 0.2% |
|
CL
Colgate Palmolive Co
|
$69.13B | +9.1% | +1.7% | 34.3 | 2.3% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$41.79B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EL | -2.4% | -10.2% | +22.1% | +0.6% | -10.9% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | -3.6% | -10.8% | +10.5% | -1.0% | -24.5% |
Capital returns
Latest dividend
$0.35
/ share · ex Aug 31, 2026
Paid (TTM)
$1.40
/ share · 4 payouts
Dividend yield (TTM, derived)
1.50%
Buyback program
· as of Jun 30, 2026
Authorized
—
Spent (derived)
—
Remaining
shares 25.10M
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1001250
CUSIP
518439104
13F (30d)
41 filings
19 filers
Visit website
Investor relations